Arch Biopartners's market cap is currently C$64.78M. The company's EPS TTM is C$-0.004; its P/E ratio is ―; Arch Biopartners is scheduled to report earnings on August 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
